Hailir?announced?on?September?28,?2020?that?the?trial?production?plan?of?2,000?tons?prothioconazole?fungicide?technical,?invested?and?constructed?by?its?wholly-
owned?subsidiary?Shandong?Hailir,?met?the?trial?production?conditions?after?expert?review?and?passed?the?review,?and?officially?entered?the?trial?production?stage.
Prothioconazole?has?the?good?characteristics?of?disease?prevention?and?treatment?effects,?obviously?yield?increase,?and?broad-spectrum?bactericidal?activity.?It?has?a?broad?market?prospect.?The?production?of?prothioconazole?technical?will?bring?new?profit?growth?points?to?Hailir?and?become?a?new?engine?for?its?high-quality?development,?which?will?help?further?consolidate,?enhance?and?optimize?its?core?competitiveness,?and?have?a?positive?impact?on?the?continuous?growth?of?the?company's?future?performance.
It?is?understood?that?Hailir?is?actively?planning?to?add?the?second?projects?for?20,000?tons?of?prothioconazole’s?key?intermediate?and?5,000?tons?of?prothioconazole?technical?production?capacity.